Default Category
-
Product Portfolio Management at Genentech
Schulman, Kevin A; Gresh, JamieCase HBS-317012-EFinanceGenentech, long the darling of the biotechnology industry, was acquired by Swiss pharmaceutical company Roche in 2009. The combined company retains the name Genentech in the US, but must now move to achieve the promises made at the time of this merger-to build from made Genentech great. One of the key tasks for Genentech CEO Ian Clark and CFO Ashraf Hanna was to implement a new portfolio management process for the combined entity. This case explo...Starting at €8.20
-
PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World
Schulman, Kevin A; Moodley, Sashidaran; Vasudevan, AnantCase HBS-317103-EEntrepreneurshipPharmAccess is an Amsterdam based NGO working to support the development of the private health care market in Africa. This work is critical as over 50% of care is delivered through the private sector, but well-intentioned efforts to address global health through the public sector have the unintended consequence of crowding-out capital formation in the private sector. PharmaAccess is working to crowd-in funding instead through the development of a...Starting at €8.20
-
Obesity Management at Kaiser Permanente: A New Mindset for Healthcare Delivery
Schulman, Kevin A; Leya, Gregory; Beveridge, ChristianaCase HBS-317106-EStrategyKaiser Permanente (KP) is the largest managed care organization in the US with over 10 million members. KP evolved from a pre-payment or capitation model that focuses the organization around the efficiency of care and the health of the population it serves. This financial model is in stark contrast to the fee-for-service payment model for other health care organizations. Given the epidemic of obesity in the US, KP is facing an enormous potential ...Starting at €8.20
-
Verily Life Sciences and Machine Learning
Schulman, Kevin A; Ho, KevinCase SGSB-SM335-EStrategyVerily Life Sciences, an independent subsidiary of Alphabet, Inc., set out to harness machine learning in the health care field. The company sought partnerships with academic research institutions, legacy life sciences companies, and hospitals and health systems to develop tools to collect and organize health data, with the goal of creating platforms that utilized the insights from that data to enhance patient care. The case study discusses these...Starting at €8.20
-
AbbVie
Schulman, Kevin A; Little, Laura; Mullangi, Samyukta; Schleicher, StephenCase HBS-316095-EThis case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds it's largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars market entrants, and a series of adverse financial forecasts for AbbVie. Given all of these risks, did the acquisition add value to shareholders? AbbVie made headlines in March 2015 wh...Starting at €8.20
-
Savannah Informatics
Schulman, Kevin ACase HBS-316111-EJohn Muthee and Justus Paul are recent graduates of medical school and a unique program in clinical inforamtics. They return to Nairobi, Kenya with a passion to make a difference in their community. They have a team they know well, but need to find a project concept for a new company. Eventually, they focus on what they believe to be a significant opportunity-supporting health insurance with an electronic eligibility verification and claim submis...Starting at €8.20